TDP-43 and FUS/TLS: Sending a complex message about messenger RNA in amyotrophic lateral sclerosis?

FEBS Journal

Volumn 278, Issue 19, 2011, Pages 3569-3577

  Strong, Michael J ^a   Volkening, Kathryn ^a  

^a WESTERN UNIVERSITY   (Canada)

Author keywords

amyotrophic lateral sclerosis; FUS TLS; RNA binding protein; RNA metabolism; RNA stability; TDP 43

Indexed keywords

BINDING PROTEIN; FUSED IN SARCOMA PROTEIN; MESSENGER RNA; MICRORNA; TAR DNA BINDING PROTEIN; UNCLASSIFIED DRUG;

AMYOTROPHIC LATERAL SCLEROSIS; BINDING AFFINITY; COMPLEX FORMATION; HUMAN; NONHUMAN; PATHOGENICITY; PRIORITY JOURNAL; PROTEIN DNA INTERACTION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN RNA BINDING; REVIEW; RNA METABOLISM; RNA PROCESSING; RNA TRANSLATION; RNA TRANSPORT; STRUCTURAL HOMOLOGY; STRUCTURE ACTIVITY RELATION; TRANSCRIPTION REGULATION;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; DNA; DNA-BINDING PROTEINS; HUMANS; PROTEIN STRUCTURE, TERTIARY; RNA, MESSENGER; RNA-BINDING PROTEIN FUS;

EID: 80052962642     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2011.08277.x     Document Type: Review

References (81)

1. Arai T, Hasegawa M, Akiyama H, Ikeda K, Nonaka T, Mori H, Mann D, Tsuchiya K, Yoshida M, Hashizume Y, et al. (2006) TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun 351, 602-611. (Pubitemid 44708852)
2. Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, Bruce J, Schuck T, Grossman M, Clark CM, et al. (2006) Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314, 130-133. (Pubitemid 44547757)
3. Strong MJ, Grace GM, Freedman M, Lomen-Hoerth C, Woolley S, Goldstein LH, Murphy J, Shoesmith C, Rosenfeld J, Leigh PN, et al. (2009) Consensus criteria for the diagnosis of frontotemporal cognitive and behavioural syndromes in amyotrophic lateral sclerosis. Amyotroph Lateral Scler 10, 131-146.
4. Strong MJ, (2008) The syndromes of frontotemporal dysfunction in amyotrophic lateral sclerosis. Amyotroph Lateral Scler 9, 323-338.
5. Baloh RH, (2011) TDP-43: the relationship between protein aggregation and neurodegeneration in amyotrophic lateral sclerosis and frontotemporal lobar degeneration. FEBS J 278, 3539-3549.
6. Lagier-Tourenne C, Polymenidou M, &, Cleveland DW, (2010) TDP-43 and FUS/TLS: emerging roles in RNA processing and neurodegeneration. Hum Mol Genet 19, R46-R64.
7. Kwiatkowski TJ Jr, Bosco DA, Leclerc AL, Tamrazian E, Vanderburg CR, Russ C, Davis A, Gilchrist J, Kasarskis EJ, Munsat T, et al. (2009) Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science 323, 1205-1208.
8. Vance C, Rogelj B, Hortobagyi T, De Vos KJ, Nishimura AL, Sreedharan J, Hu X, Smith B, Ruddy D, Wright P, et al. (2009) Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science 323, 1208-1211.
9. Strong MJ, (2010) The evidence for altered RNA metabolism in amyotrophic lateral sclerosis (ALS). J Neurol Sci 288, 1-12.
10. Colombrita C, Onesto E, Tiloca C, Ticozzi N, Silani V, &, Ratti A, (2011) RNA-binding proteins and RNA metabolism: a new scenario in the pathogenesis of amyotrophic lateral sclerosis. Arch Ital Biol 149, 83-99.
11. Freibaum BD, Chitta RK, High AA, &, Taylor JP, (2010) Global analysis of TDP-43 interacting proteins reveals strong association with RNA splicing and translation machinery. J Proteome Res 9, 1104-1120.
12. Sephton CF, Cenik C, Kucukural A, Dammer EB, Cenik B, Han YH, Dewey CM, Roth FP, Herz J, Peng J, et al. (2011) Identification of neuronal RNA targets of TDP-43-containing ribonucleoprotein complexes. J Biol Chem 286, 1204-1215.
13. Iko Y, Kodama TS, Kasai N, Oyama T, Morita EH, Muto T, Okumura M, Fujii R, Takumi T, Tate S, et al. (2004) Domain architectures and characterization of an RNA-binding protein, TLS. J Biol Chem 279, 44834-44840. (Pubitemid 39430895)
14. Buchan JR, &, Parker R, (2009) Eukaryotic stress granules: the ins and outs of translation. Mol Cell 36, 932-941.
15. Loschi M, Leishman CC, Berardone N, &, Boccaccio GL, (2009) Dynein and kinesin regulate stress-granule and P-body dynamics. J Cell Sci 122, 3973-3982.
16. Parker R, &, Sheth U, (2007) P bodies and the control of mRNA translation and degradation. Mol Cell 25, 635-646. (Pubitemid 46341926)
17. Sheth U, &, Parker R, (2003) Decapping and decay of messenger RNA occur in cytoplasmic processing bodies. Science 300, 805-808. (Pubitemid 36532117)
18. Mukherjee D, Gao M, O'Connor JP, Raijmakers R, Pruijn G, Lutz CS, &, Wilusz J, (2002) The mammalian exosome mediates the efficient degradation of mRNAs that contain AU-rich elements. EMBO J 21, 165-174. (Pubitemid 34087085)
19. Houseley J, LaCava J, &, Tollervey D, (2006) RNA-quality control by the exosome. Nat Rev Mol Cell Biol 7, 529-539. (Pubitemid 44036458)
20. Chen CY, Gherzi R, Ong SE, Chan EL, Raijmakers R, Pruijn GJ, Stoecklin G, Moroni C, Mann M, &, Karin M, (2001) AU binding proteins recruit the exosome to degrade ARE-containing mRNAs. Cell 107, 451-464. (Pubitemid 33152781)
21. Macfarlane LA, &, Murphy PR, (2010) MicroRNA: biogenesis, function and role in cancer. Curr Genomics 11, 537-561.
22. Fiesel FC, &, Kahle PJ, (2011) TDP-43 and FUS/TLS: cellular functions and implications for neurodegeneration. FEBS J 278, 3550-3568.
23. Gregory RI, Yan KP, Amuthan G, Chendrimada T, Doratotaj B, Cooch N, &, Shiekhattar R, (2004) The microprocessor complex mediates the genesis of microRNAs. Nature 432, 235-240. (Pubitemid 39545855)
24. Liu X, Fortin K, &, Mourelatos Z, (2008) MicroRNAs: biogenesis and molecular functions. Brain Pathol 18, 113-121.
25. Pillai RS, (2005) MicroRNA function: multiple mechanisms for a tiny RNA? RNA 11, 1753-1761. (Pubitemid 41720024)
26. Jabri E, (2005) P-bodies take a RISC. Nat Struct Mol Biol 12, 564. (Pubitemid 40980799)
27. Nelson PT, Wang WX, &, Rajeev BW, (2008) MicroRNAs (miRNAs) in neurodegenerative diseases. Brain Pathol 18, 130-138.
28. Orom UA, Nielsen FC, &, Lund AH, (2008) MicroRNA-10a binds the 5′UTR of ribosomal protein mRNAs and enhances their translation. Mol Cell 30, 460-471. (Pubitemid 351672378)
29. Chaudhury A, Chander P, &, Howe PH, (2010) Heterogeneous nuclear ribonucleoproteins (hnRNPs) in cellular processes: focus on hnRNP E1′s multifunctional regulatory roles. RNA 16, 1449-1462.
30. Singh R, &, Valcarcel J, (2005) Building specificity with nonspecific RNA-binding proteins. Nat Struct Mol Biol 12, 645-653. (Pubitemid 43086269)
31. Krecic AM, &, Swanson MS, (1999) hnRNP complexes: composition, structure, and function. Curr Opin Cell Biol 11, 363-371. (Pubitemid 29273808)
32. Buratti E, &, Baralle FE, (2011) TDP-43: new aspects of autoregulation mechanisms in RNA binding proteins and their connection with human disease. FEBS J 278, 3530-3538.
33. Zhang YJ, Xu YF, Dickey CA, Buratti E, Baralle F, Bailey R, Pickering-Brown S, Dickson D, &, Petrucelli L, (2007) Progranulin mediates caspase-dependent cleavage of TAR DNA binding protein-43. J Neurosci 27, 10530-10534. (Pubitemid 47501990)
34. Kino Y, Washizu C, Aquilanti E, Okuno M, Kurosawa M, Yamada M, Doi H, &, Nukina N, (2011) Intracellular localization and splicing regulation of FUS/TLS are variably affected by amyotrophic lateral sclerosis-linked mutations. Nucleic Acids Res 39, 2781-2798.
35. Buratti E, &, Baralle FE, (2001) Characterization and functional implications of the RNA binding properties of nuclear factor TDP-43, a novel splicing regulator of CFTR exon 9. J Biol Chem 276, 36337-36343.
36. Strong MJ, Volkening K, Hammond R, Yang W, Strong W, Leystra-Lantz C, &, Shoesmith C, (2007) TDP43 is a human low molecular weight neurofilament (hNFL) mRNA-binding protein. Mol Cell Neurosci 35, 320-327. (Pubitemid 46843567)
37. Volkening K, Leystra-Lantz C, Yang W, Jaffee H, &, Strong MJ, (2009) Tar DNA binding protein of 43 kDa (TDP-43), 14-3-3 proteins and copper/zinc superoxide dismutase (SOD1) interact to modulate NFL mRNA stability. Implications for altered RNA processing in amyotrophic lateral sclerosis (ALS). Brain Res 1305, 168-182.
38. Kim SH, Shanware N, Bowler MJ, &, Tibbetts RS, (2010) ALS-associated proteins TDP-43 and FUS/TLS function in a common biochemical complex to coregulate HDAC6 mRNA. J Biol Chem 285, 34097-34105.
39. Ayala YM, De CL, Avendano-Vazquez SE, Dhir A, Romano M, D'Ambrogio A, Tollervey J, Ule J, Baralle M, Buratti E, et al. (2011) TDP-43 regulates its mRNA levels through a negative feedback loop. EMBO J 30, 277-288.
40. Sephton CF, Good SK, Atkin S, Dewey CM, Mayer P III, Herz J, &, Yu G, (2010) TDP-43 is a developmentally regulated protein essential for early embryonic development. J Biol Chem 285, 6826-6834.
41. Lerga A, Hallier M, Delva L, Orvain C, Gallais I, Marie J, &, Moreau-Gachelin F, (2001) Identification of an RNA binding specificity for the potential splicing factor TLS. J Biol Chem 276, 6807-6816.
42. Yang S, Warraich ST, Nicholson GA, &, Blair IP, (2010) Fused in sarcoma/translocated in liposarcoma: a multifunctional DNA/RNA binding protein. Int J Biochem Cell Biol 42, 1408-1411.
43. Baechtold H, Kuroda M, Sok J, Ron D, Lopez BS, &, Akhmedov AT, (1999) Human 75-kDa DNA-pairing protein is identical to the pro-oncoprotein TLS/FUS and is able to promote D-loop formation. J Biol Chem 274, 34337-34342. (Pubitemid 129511776)
44. Crozat A, Aman P, Mandahl N, &, Ron D, (1993) Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma. Nature 363, 640-644. (Pubitemid 23227627)
45. Prasad DD, Ouchida M, Lee L, Rao VN, &, Reddy ES, (1994) TLS/FUS fusion domain of TLS/FUS-erg chimeric protein resulting from the t(16;21) chromosomal translocation in human myeloid leukemia functions as a transcriptional activation domain. Oncogene 9, 3717-3729. (Pubitemid 24359413)
46. Fujii R, Okabe S, Urushido T, Inoue K, Yoshimura A, Tachibana T, Nishikawa T, Hicks GG, &, Takumi T, (2005) The RNA binding protein TLS is translocated to dendritic spines by mGluR5 activation and regulates spine morphology. Curr Biol 15, 587-593. (Pubitemid 40413401)
47. Kanai Y, Dohmae N, &, Hirokawa N, (2004) Kinesin transports RNA: isolation and characterization of an RNA-transporting granule. Neuron 43, 513-525. (Pubitemid 39094678)
48. Fujii R, &, Takumi T, (2005) TLS facilitates transport of mRNA encoding an actin-stabilizing protein to dendritic spines. J Cell Sci 118, 5755-5765. (Pubitemid 43079269)
49. Ou SH, Wu F, Harrich D, Garcia-Martinez LF, &, Gaynor RB, (1995) Cloning and characterization of a novel cellular protein, TDP-43, that binds to human immunodeficiency virus type 1 TAR DNA sequence motifs. J Virol 69, 3584-3596.
50. Abhyankar MM, Urekar C, &, Reddi PP, (2007) A novel CpG-free vertebrate insulator silences the testis-specific SP-10 gene in somatic tissues: role for TDP-43 in insulator function. J Biol Chem 282, 36143-36154.
51. He Y, &, Smith R, (2009) Nuclear functions of heterogeneous nuclear ribonucleoproteins A/B. Cell Mol Life Sci 66, 1239-1256.
52. Buratti E, Dork T, Zuccato E, Pagani F, Romano M, &, Baralle FE, (2001) Nuclear factor TDP-43 and SR proteins promote in vitro and in vivo CFTR exon 9 skipping. EMBO J 20, 1774-1784. (Pubitemid 32299413)
53. Ayala YM, Pagani F, &, Baralle FE, (2006) TDP43 depletion rescues aberrant CFTR exon 9 skipping. FEBS Lett 580, 1339-1344. (Pubitemid 43221997)
54. Buratti E, Brindisi A, Pagani F, &, Baralle FE, (2004) Nuclear factor TDP-43 binds to the polymorphic TG repeats in CFTR intron 8 and causes skipping of exon 9: a functional link with disease penetrance. Am J Hum Genet 74, 1322-1325. (Pubitemid 38669335)
55. Mercado PA, Ayala YM, Romano M, Buratti E, &, Baralle FE, (2005) Depletion of TDP 43 overrides the need for exonic and intronic splicing enhancers in the human apoA-II gene. Nucleic Acids Res 33, 6000-6010. (Pubitemid 41742619)
56. Bose JK, Wang IF, Hung L, Tarn WY, &, Shen CK, (2008) TDP-43 overexpression enhances exon 7 inclusion during the survival of motor neuron pre-mRNA splicing. J Biol Chem 283, 28852-28859.
57. Shan X, Chiang PM, Price DL, &, Wong PC, (2010) Altered distributions of Gemini of coiled bodies and mitochondria in motor neurons of TDP-43 transgenic mice. Proc Natl Acad Sci USA 107, 16325-16330.
58. Elvira G, Wasiak S, Blandford V, Tong XK, Serrano A, Fan X, del RS-C, Servant F, Bell AW, Boismenu D, et al. (2006) Characterization of an RNA granule from developing brain. Mol Cell Proteomics 5, 635-651.
59. Wang IF, Reddy NM, &, Shen CK, (2002) Higher order arrangement of the eukaryotic nuclear bodies. Proc Natl Acad Sci USA 99, 13583-13588. (Pubitemid 35215425)
60. Moisse K, Volkening K, Leystra-Lantz C, Welch I, Hill T, &, Strong MJ, (2009) Divergent patterns of cytosolic TDP-43 and neuronal progranulin expression following axotomy: implications for TDP-43 in the physiological response to neuronal injury. Brain Res 1249, 202-211.
61. Wang IF, Wu LS, Chang HY, &, Shen CK, (2008) TDP-43, the signature protein of FTLD-U, is a neuronal activity-responsive factor. J Neurochem 105, 797-806.
62. Colombrita C, Zennaro E, Fallini C, Weber M, Sommacal A, Buratti E, Silani V, &, Ratti A, (2009) TDP-43 is recruited to stress granules in conditions of oxidative insult. J Neurochem 111, 1051-1061.
63. Moisse K, Mepham J, Volkening K, Welch I, Hill T, &, Strong MJ, (2009) Cytosolic TDP-43 expression following axotomy is associated with caspase 3 activation in NFL-/- mice: support for a role for TDP-43 in the physiological response to neuronal injury. Brain Res 1296, 176-186.
64. Ge WW, Wen W, Strong W, Leystra-Lantz C, &, Strong MJ, (2005) Mutant copper-zinc superoxide dismutase binds to and destabilizes human low molecular weight neurofilament mRNA. J Biol Chem 280, 118-124. (Pubitemid 40164972)
65. Law WJ, Cann KL, &, Hicks GG, (2006) TLS, EWS and TAF15: a model for transcriptional integration of gene expression. Brief Funct Genomic Proteomic 5, 8-14. (Pubitemid 46402988)
66. Andersson MK, Stahlberg A, Arvidsson Y, Olofsson A, Semb H, Stenman G, Nilsson O, &, Aman P, (2008) The multifunctional FUS, EWS and TAF15 proto-oncoproteins show cell type-specific expression patterns and involvement in cell spreading and stress response. BMC Cell Biol 9, 37.
67. Yang L, Embree LJ, Tsai S, &, Hickstein DD, (1998) Oncoprotein TLS interacts with serine-arginine proteins involved in RNA splicing. J Biol Chem 273, 27761-27764. (Pubitemid 28496059)
68. Geser F, Brandmeir NJ, Kwong LK, Martinez-Lage M, Elman L, McCluskey L, Xie SX, Lee VM, &, Trojanowski JQ, (2008) Evidence of multisystem disorder in whole-brain map of pathological TDP-43 in amyotrophic lateral sclerosis. Arch Neurol 65, 636-641. (Pubitemid 351679659)
69. Mishra M, Paunesku T, Woloschak GE, Siddique T, Zhu LJ, Lin S, Greco K, &, Bigio EH, (2007) Gene expression analysis of frontotemporal lobar degeneration of the motor neuron disease type with ubiquitinated inclusions. Acta Neuropathol 114, 81-94. (Pubitemid 47029063)
70. Wong NK, He BP, &, Strong MJ, (2000) Characterization of neuronal intermediate filament protein expression in cervical spinal motor neurons in sporadic amyotrophic lateral sclerosis (ALS). J Neuropathol Exp Neurol 59, 972-982.
71. Dewey CM, Cenik B, Sephton CF, Dries DR, Mayer P III, Good SK, Johnson BA, Herz J, &, Yu G, (2011) TDP-43 is directed to stress granules by sorbitol, a novel physiological osmotic and oxidative stressor. Mol Cell Biol 31, 1098-1108.
72. Bosco DA, Lemay N, Ko HK, Zhou H, Burke C, Kwiatkowski TJ Jr, Sapp P, McKenna-Yasek D, Brown RH Jr, &, Hayward LJ, (2010) Mutant FUS proteins that cause amyotrophic lateral sclerosis incorporate into stress granules. Hum Mol Genet 19, 4160-4175.
73. Tateishi T, Hokonohara T, Yamasaki R, Miura S, Kikuchi H, Iwaki A, Tashiro H, Furuya H, Nagara Y, Ohyagi Y, et al. (2010) Multiple system degeneration with basophilic inclusions in Japanese ALS patients with FUS mutation. Acta Neuropathol 119, 355-364.
74. Suzuki N, Aoki M, Warita H, Kato M, Mizuno H, Shimakura N, Akiyama T, Furuya H, Hokonohara T, Iwaki A, et al. (2010) FALS with FUS mutation in Japan, with early onset, rapid progress and basophilic inclusion. J Hum Genet 55, 252-254.
75. Fuentealba RA, Udan M, Bell S, Wegorzewska I, Shao J, Diamond MI, Weihl CC, &, Baloh RH, (2010) Interaction with polyglutamine aggregates reveals a Q/N-rich domain in TDP-43. J Biol Chem 285, 26304-26314.
76. Udan M, &, Baloh RH, (2011) Implications of the prion-related Q/N domains in TDP-43 and FUS. Prion 5, 1-5.
77. Ling SC, Albuquerque CP, Han JS, Lagier-Tourenne C, Tokunaga S, Zhou H, &, Cleveland DW, (2010) ALS-associated mutations in TDP-43 increase its stability and promote TDP-43 complexes with FUS/TLS. Proc Natl Acad Sci USA 107, 13318-13323.
78. Dormann D, Rodde R, Edbauer D, Bentmann E, Fischer I, Hruscha A, Than ME, Mackenzie IR, Capell A, Schmid B, et al. (2010) ALS-associated fused in sarcoma (FUS) mutations disrupt Transportin-mediated nuclear import. EMBO J 29, 2841-2857.
79. Gal J, Zhang J, Kwinter DM, Zhai J, Jia H, Jia J, &, Zhu H, (2010) Nuclear localization sequence of FUS and induction of stress granules by ALS mutants. Neurobiol Aging, doi:10.1016/j.neurobiolaging.2010.06.010
80. Neumann M, Kwong LK, Lee EB, Kremmer E, Flatley A, Xu Y, Forman MS, Troost D, Kretzschmar HA, Trojanowski JQ, et al. (2009) Phosphorylation of S409/410 of TDP-43 is a consistent feature in all sporadic and familial forms of TDP-43 proteinopathies. Acta Neuropathol 117, 137-149.
81. Keene JD, &, Tenenbaum SA, (2002) Eukaryotic mRNPs may represent posttranscriptional operons. Mol Cell 9, 1161-1167. (Pubitemid 34722296)